You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Getting Social About Constipation: Enhancing the Patient-Provider Dialogue

  • Authors: Darren M. Brenner, MD; Amol Sharma, MD, MS; Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE; Erin Slater
  • CME / ABIM MOC / CE Released: 8/16/2022
  • Valid for credit through: 8/16/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.75 ABIM MOC points

    Nurses - 0.75 ANCC Contact Hour(s) (0.25 contact hours are in the area of pharmacology)

    IPCE - 0.75 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for primary care physicians, gastroenterologists, obstetricians, gynecologists, nurses, and other clinicians who treat patients with chronic constipation.

The goal of this activity is that learners will be better able to manage chronic idiopathic constipation (CIC) through application of evidence-based diagnostic criteria to facilitate timely diagnosis, selection of evidence-based treatments, interprofessional management, and shared decision-making with patients.

Upon completion of this activity, participants will:

  • Have greater competence related to
    • Applying evidence-based diagnostic criteria for the assessment of patients with chronic constipation
    • Selecting evidence-based management strategies for patients with CIC within an interprofessional team setting
  • Demonstrate greater confidence in their ability to
    • Engage patients in a dialogue and shared decision-making regarding their CIC care


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Darren M. Brenner, MD

    Associate Professor of Medicine
    (Gastroenterology and Hepatology) and Surgery
    Northwestern University Feinberg School of Medicine
    Chicago, Illinois

     

    Disclosures

    Darren M. Brenner, MD, has the following relevant financial relationships:
    Consultant or advisor for: Abbvie; Alnylam; Alpha Sigma; Ardelyx; Arena; Bayer; Gemelli; Ironwood; QoL Medical; Redhill; Salix; Takeda 
    Speaker or member of speakers bureau for: Abbvie; Alpha Sigma; Ironwood; Redhill; Salix; Takeda

  • Amol Sharma, MD, MS

    Associate Professor
    Division of Gastroenterology & Hepatology
    Medical College of Georgia
    Augusta University (formerly Georgia Regents University)
    Augusta, Georgia

     

    Disclosures

    Amol Sharma, MD, MS, has the following relevant financial relationships:
    Consultant or advisor for: Phathom Pharmaceuticals; Takeda Pharmaceuticals
    Research funding from: Vibrant Inc.

  • Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE

    Dan and Lillie Sterling Professor of Medicine
    McGovern Medical School
    Chief
    Gastroenterology, Hepatology, and Nutrition
    University of Texas Health Science Center
    Houston, Texas

     

    Disclosures

    Brooks Cash, MD, AGAF, FACG, FACP, FASGE, has the following relevant financial relationships:
    Consultant or advisor for: Phathom Pharmaceuticals; Redhill
    Speaker or member of speakers bureau for: Redhill

Patient

  • Erin Slater

    Disclosures

    Erin Slater has no relevant financial relationships.

Editors

  • Roderick Smith, MS

    Senior Medical Education Director, Medscape, LLC

    Disclosures

    Roderick Smith, MS, has no relevant financial relationships.

  • Renata Feldman, PharmD

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Renata Feldman, PharmD, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

Developed through a partnership between Medscape and International Foundation for Gastrointestinal Disorders. 



In support of improving patient care, Medscape LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Getting Social About Constipation: Enhancing the Patient-Provider Dialogue

Authors: Darren M. Brenner, MD; Amol Sharma, MD, MS; Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE; Erin SlaterFaculty and Disclosures

CME / ABIM MOC / CE Released: 8/16/2022

Valid for credit through: 8/16/2023

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Overview of Chronic Idiopathic Constipation (CIC)

How much do you know about the pathophysiology of constipation?
Darren M. Brenner, MD

Burden of Chronic Idiopathic Constipation: A Patient’s Story

Hear a patient’s perspective on living with chronic constipation.
Darren M. Brenner, MD; Erin Slater

Diagnosing Constipation in Practice

Can you differentiate CIC from other types of chronic constipation?
Amol Sharma, MD, MS

Chronic Idiopathic Constipation Management Part 1: Nonpharmacologic and Over-the-Counter Treatments

How effective are dietary interventions and laxatives as initial CIC treatments?
Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE

Chronic Idiopathic Constipation Management Part 2: Prescription Medications

Did you know there are FDA-approved prescription medications for CIC?
Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE

Tips for Individualizing Chronic Idiopathic Constipation Management

Hear how Erin is doing and Dr Brenner’s tips for managing constipation
Darren M. Brenner, MD; Erin Slater
 

Learning Feedback Questions

Before you begin, please take this brief survey.

  • Print